We've found
31,654
archived clinical trials in
Cardiology
We've found
31,654
archived clinical trials in
Cardiology
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery
Updated: 10/5/2015
A Randomized, Double-Blind, Double-Dummy, Parallel Group Study to Compare YM150 Bid and qd Doses and Enoxaparin for Prevention of Venous Thromboembolism in Subjects Undergoing Elective Hip Replacement Surgery
Status: Enrolling
Updated: 10/5/2015
Click here to add this to my saved trials
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
Updated: 10/6/2015
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 10/6/2015
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction(HFpEF)
Updated: 10/6/2015
Reduced Contractile Reserve: a Therapeutic Target in Heart Failure With Preserved Ejection Fraction
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
Updated: 10/6/2015
Surgical Treatment for Ischemic Heart Failure (STICH)
Status: Enrolling
Updated: 10/6/2015
Comparison of Surgical and Medical Treatment for Congestive Heart Failure and Coronary Artery Disease
Updated: 10/6/2015
Surgical Treatment for Ischemic Heart Failure (STICH)
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
Beta-2 Polymorphisms and Beta Receptor Selectivity
Updated: 10/6/2015
The Effects of ß2 Polymorphisms on Beta Selectivity After ß-adrenergic Blockade in Patients With Heart Failure
Status: Enrolling
Updated: 10/6/2015
Beta-2 Polymorphisms and Beta Receptor Selectivity
Updated: 10/6/2015
The Effects of ß2 Polymorphisms on Beta Selectivity After ß-adrenergic Blockade in Patients With Heart Failure
Status: Enrolling
Updated: 10/6/2015
Click here to add this to my saved trials
A Study Comparing Two Spinal Techniques for for Cesarean Delivery Anesthesia
Updated: 10/7/2015
Spinal Anesthesia for Cesarean Delivery: The Wiley Spinal Catheter Intermittent Bolus Technique Versus Single Shot Spinal Anesthesia
Status: Enrolling
Updated: 10/7/2015
A Study Comparing Two Spinal Techniques for for Cesarean Delivery Anesthesia
Updated: 10/7/2015
Spinal Anesthesia for Cesarean Delivery: The Wiley Spinal Catheter Intermittent Bolus Technique Versus Single Shot Spinal Anesthesia
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET)
Updated: 10/7/2015
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With Heart Failure
Status: Enrolling
Updated: 10/7/2015
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With HF (TARGET)
Updated: 10/7/2015
Targeted Intervention to Improve Medication Adherence in Cognitively Impaired Patients With Heart Failure
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Phase II Study of the Effect of CK-1827452 Injection on Myocardial Efficiency
Updated: 10/7/2015
A Phase II Open-Label Study to Investigate the Effects of CK-1827452 Injection on Ventricular Performance, Myocardial Oxygen Consumption, and Myocardial Efficiency in Patients With Heart Failure and Left Ventricular Systolic Dysfunction
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)
Updated: 10/7/2015
Utah Center for the Collaborative Study of the Role of the Macular Pigment Carotenoids in the Pathogenesis and Treatment of MacTel
Status: Enrolling
Updated: 10/7/2015
The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)
Updated: 10/7/2015
Utah Center for the Collaborative Study of the Role of the Macular Pigment Carotenoids in the Pathogenesis and Treatment of MacTel
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
PRESERVE-Zenith® Iliac Branch System Clinical Extended Study
Updated: 10/7/2015
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation With the ConnectSX™
Status: Enrolling
Updated: 10/7/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Safety and Efficacy of Direct Blood Volume Measurement in the Treatment of Heart Failure
Updated: 10/8/2015
Treating to Euvolemia by Clinical Assessment and Measured Blood Volume in Heart Failure
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
A Phase 2, Multi-Center Study To Compare The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist With Ranibizumab In Adults With Diabetic Macular Edema
Updated: 10/8/2015
A Phase 2, Randomized, Double-masked, Placebo-controlled, Parallel Group, Multi-center Study To Compare The Efficacy And Safety Of A Chemokine Ccr2/5 Receptor Antagonist (Pf-04634817) With That Of Ranibizumab In Adult Subjects With Diabetic Macular Edema
Status: Enrolling
Updated: 10/8/2015
Click here to add this to my saved trials